Theriva Biologics (TOVX) Short Interest Ratio & Short Volume $1.98 -0.01 (-0.50%) (As of 12:50 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesInsider TradesShort Interest Theriva Biologics Short Interest DataTheriva Biologics (TOVX) has a short interest of 79,000 shares, representing 3.56% of the float (the number of shares available for trading by the public). This marks a -18.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.02 million shares to cover all short positions.Current Short Interest79,000 sharesPrevious Short Interest96,900 sharesChange Vs. Previous Month-18.47%Dollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares2,270,000 sharesFloat Size2,220,000 sharesShort Percent of Float3.56%Today's Trading Volume1,319,243 sharesAverage Trading Volume1,019,553 sharesToday's Volume Vs. Average129% Short Selling Theriva Biologics? Sign up to receive the latest short interest report for Theriva Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTOVX Short Interest Over TimeTOVX Days to Cover Over TimeTOVX Percentage of Float Shorted Over Time Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Theriva Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202479,000 shares $0.00 -18.5%3.6%0 $0.00 9/30/202496,900 shares $0.00 +6.5%4.4%0.1 $0.00 9/15/202491,000 shares $0.00 -62.9%6.8%0.2 $0.00 8/31/2024245,200 shares $0.00 +6,030.0%24.8%0.4 $0.00 8/15/20244,000 shares $0.00 -91.4%0.0%0.1 $0.00 7/31/202446,300 shares $0.00 +60.2%0.3%0.1 $0.00 Get the Latest News and Ratings for TOVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theriva Biologics and its competitors with MarketBeat's FREE daily newsletter. 7/15/202428,900 shares $0.00 -93.7%0.2%0 $0.00 6/30/2024457,800 shares $0.00 -21.7%2.7%0.8 $0.00 6/15/2024584,300 shares $0.00 -14.5%3.5%1 $0.00 5/31/2024683,200 shares $0.00 +67.7%4.0%1.2 $0.00 5/15/2024407,300 shares $0.00 -18.3%2.4%0.8 $0.00 4/30/2024498,600 shares $0.00 +26.3%3.0%3.3 $0.00 4/15/2024394,800 shares $0.00 -3.9%2.4%3 $0.00 3/31/2024411,000 shares $0.00 +13.4%2.5%4.2 $0.00 3/15/2024362,600 shares $0.00 +4.1%2.2%3.3 $0.00 2/29/2024348,200 shares $0.00 +0.7%2.1%5.4 $0.00 2/15/2024345,800 shares $0.00 -1.0%2.1%5.2 $0.00 1/31/2024349,100 shares $0.00 -4.2%2.1%5 $0.00 1/15/2024364,500 shares $0.00 +5.4%2.2%6.1 $0.00 12/31/2023345,800 shares $0.00 -8.4%2.1%5.8 $0.00 12/15/2023377,400 shares $0.00 -2.0%2.3%6.9 $0.00 11/30/2023384,900 shares $0.00 +9.4%2.3%8.7 $0.00 11/15/2023351,900 shares $0.00 -14.9%2.1%8.2 $0.00 10/31/2023413,400 shares $0.00 -3.5%2.5%8.9 $0.00 10/15/2023428,200 shares $0.00 +5.6%2.6%7.2 $0.00 9/30/2023405,600 shares $0.00 -14.6%2.4%5.4 $0.00 9/15/2023474,800 shares $0.00 +8.1%2.8%0.6 $0.00 8/31/2023439,100 shares $0.00 +5.9%2.6%0.6 $0.00 8/15/2023414,700 shares $0.00 -5.3%2.5%0.6 $0.00 7/31/2023437,900 shares $0.00 -9.7%3.0%0.6 $0.00 7/15/2023484,700 shares $0.00 -76.5%3.3%0.7 $0.00 6/30/20232,060,000 shares $0.00 +413.1%13.9%3 $0.00 6/15/2023401,500 shares $0.00 +5.8%2.7%5.3 $0.00 5/31/2023379,400 shares $0.00 -1.6%2.6%11.9 $0.00 5/15/2023385,500 shares $0.00 No Change2.6%11.7 $0.00 TOVX Short Interest - Frequently Asked Questions What is Theriva Biologics' current short interest? Short interest is the volume of Theriva Biologics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 79,000 shares of TOVX short. 3.56% of Theriva Biologics' shares are currently sold short. Learn More on Theriva Biologics' current short interest. What is a good short interest percentage for Theriva Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.56% of Theriva Biologics' floating shares are currently sold short. Is Theriva Biologics' short interest increasing or decreasing? Theriva Biologics saw a decrease in short interest in October. As of October 15th, there was short interest totaling 79,000 shares, a decrease of 18.5% from the previous total of 96,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Theriva Biologics' float size? Theriva Biologics currently has issued a total of 2,270,000 shares. Some of Theriva Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theriva Biologics currently has a public float of 2,220,000 shares. How does Theriva Biologics' short interest compare to its competitors? 3.56% of Theriva Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Theriva Biologics: Biora Therapeutics, Inc. (4.13%), Alzamend Neuro, Inc. (5.39%), Aytu BioPharma, Inc. (3.78%), Apollomics, Inc. (0.50%), Antibe Therapeutics Inc. (0.12%), Kiora Pharmaceuticals, Inc. (0.14%), Vincerx Pharma, Inc. (2.82%), Addex Therapeutics Ltd (1.21%), Edesa Biotech, Inc. (0.90%), Indaptus Therapeutics, Inc. (0.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Theriva Biologics stock? Short selling TOVX is an investing strategy that aims to generate trading profit from Theriva Biologics as its price is falling. TOVX shares are trading up $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Theriva Biologics? A short squeeze for Theriva Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOVX, which in turn drives the price of the stock up even further. How often is Theriva Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOVX, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Biora Therapeutics Short Interest Alzamend Neuro Short Interest Aytu BioPharma Short Interest Apollomics Short Interest Antibe Therapeutics Short Interest Kiora Pharmaceuticals Short Interest Vincerx Pharma Short Interest Addex Therapeutics Short Interest Edesa Biotech Short Interest Indaptus Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:TOVX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theriva Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theriva Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.